"Penile Induration" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition characterized by hardening of the PENIS due to the formation of fibrous plaques on the dorsolateral aspect of the PENIS, usually involving the membrane (tunica albuginea) surrounding the erectile tissue (corpus cavernosum penis). This may eventually cause a painful deformity of the shaft or constriction of the urethra, or both.
Descriptor ID |
D010411
|
MeSH Number(s) |
C12.294.494.508 C17.300.715
|
Concept/Terms |
Penile Induration- Penile Induration
- Penile Fibromatosis
- Fibromatosis, Penile
- Peyronie's Disease
- Peyronies Disease
- Plastic Induration of the Penis
- Cavernitis, Fibrous
- Cavernitides, Fibrous
- Fibrous Cavernitides
- Fibrous Cavernitis
- Peyronie Disease
|
Below are MeSH descriptors whose meaning is more general than "Penile Induration".
Below are MeSH descriptors whose meaning is more specific than "Penile Induration".
This graph shows the total number of publications written about "Penile Induration" by people in this website by year, and whether "Penile Induration" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 3 | 0 | 3 |
2003 | 3 | 0 | 3 |
2004 | 3 | 0 | 3 |
2005 | 4 | 0 | 4 |
2006 | 1 | 0 | 1 |
2008 | 2 | 0 | 2 |
2009 | 1 | 0 | 1 |
2010 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Penile Induration" by people in Profiles.
-
The two phases of the clinical validation of preclinical translational mechanistic research on PDE5 inhibitors since Viagra's advent. A personal perspective. Int J Impot Res. 2019 Mar; 31(2):57-60.
-
The transcriptional signatures of cells from the human Peyronie's disease plaque and the ability of these cells to generate a plaque in a rat model suggest potential therapeutic targets. J Sex Med. 2015 Feb; 12(2):313-27.
-
The management of Peyronie's disease: evidence-based 2010 guidelines. J Sex Med. 2010 Jul; 7(7):2359-74.
-
Treatment of Peyronie's disease with PDE5 inhibitors: an antifibrotic strategy. Nat Rev Urol. 2010 Apr; 7(4):215-21.
-
Mechanisms of penile fibrosis. J Sex Med. 2009 Mar; 6 Suppl 3:353-62.
-
Experimental models of Peyronie's disease. Implications for new therapies. J Sex Med. 2009 Feb; 6(2):303-13.
-
Profibrotic role of myostatin in Peyronie's disease. J Sex Med. 2008 Jul; 5(7):1607-22.
-
Effects of long-term vardenafil treatment on the development of fibrotic plaques in a rat model of Peyronie's disease. BJU Int. 2006 Mar; 97(3):625-33.
-
Conservative management options for Peyronie's disease. Curr Urol Rep. 2005 Nov; 6(6):454-60.
-
Evidence that osteogenic progenitor cells in the human tunica albuginea may originate from stem cells: implications for peyronie disease. Biol Reprod. 2005 Dec; 73(6):1199-210.